J E Liddicoat, S M Bekassy, P C Johnson, S K Ajmani, M E DeBakey
{"title":"Tc-99m焦磷酸盐对心肌血运重建的评价。","authors":"J E Liddicoat, S M Bekassy, P C Johnson, S K Ajmani, M E DeBakey","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Early clinical application of technetium 99m labeled pyrophosphate for cardiac imaging has revealed a safe noninvasive method of determining areas of impaired myocardial perfusion in patients with atherosclerotic occlusive coronary artery disease. Using this method, we were able to demonstrate improvement in myocardial blood supply following coronary artery bypass surgery.</p>","PeriodicalId":75677,"journal":{"name":"Cardiovascular Research Center bulletin","volume":"13 1","pages":"8-14"},"PeriodicalIF":0.0000,"publicationDate":"1974-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of myocardial revascularization utilizing Tc-99m pyrophosphate.\",\"authors\":\"J E Liddicoat, S M Bekassy, P C Johnson, S K Ajmani, M E DeBakey\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Early clinical application of technetium 99m labeled pyrophosphate for cardiac imaging has revealed a safe noninvasive method of determining areas of impaired myocardial perfusion in patients with atherosclerotic occlusive coronary artery disease. Using this method, we were able to demonstrate improvement in myocardial blood supply following coronary artery bypass surgery.</p>\",\"PeriodicalId\":75677,\"journal\":{\"name\":\"Cardiovascular Research Center bulletin\",\"volume\":\"13 1\",\"pages\":\"8-14\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1974-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cardiovascular Research Center bulletin\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Research Center bulletin","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Evaluation of myocardial revascularization utilizing Tc-99m pyrophosphate.
Early clinical application of technetium 99m labeled pyrophosphate for cardiac imaging has revealed a safe noninvasive method of determining areas of impaired myocardial perfusion in patients with atherosclerotic occlusive coronary artery disease. Using this method, we were able to demonstrate improvement in myocardial blood supply following coronary artery bypass surgery.